Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): A network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): A network meta-analysis of randomized controlled trials

Published:2021-08 Issue: Volume:427 Page:117505
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Masoud Ahmed Taher,Hasan Mohammed Tarek,Sayed Ahmed,Edward Harvey Nabil,Amer Ahmed Mohamed,Naga Abdelrahman Elshahat,Elfil Mohamed,Alghamdi Badrah S.,Perveen Asma,Ashraf Ghulam Md,Bahbah Eshak I.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference34 articles.

1. Chronic migraine treatment: from OnabotulinumtoxinA onwards;Negro;Expert. Rev. Neurother.,2016

2. Spotlight on anti-CGRP monoclonal antibodies in migraine: the clinical evidence to date;Pellesi;Clin. Pharmacol. Drug Dev.,2017

3. Tracing transformation: chronic migraine classification, progression, and epidemiology;Lipton;Neurology.,2009

4. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

5. The cost of headache disorders in Europe: the Eurolight project;Linde;Eur. J. Neurol.,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis;European Journal of Pharmacology;2024-08

2. Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-05-13

3. Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review;Journal of Clinical Medicine;2024-03-28

4. Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario;Hospital Pharmacy;2023-11-25

5. Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention;Journal of Medical Economics;2023-08-26